Auto immune hepatitis.
暂无分享,去创建一个
C. V. van Nieuwkerk | Christian P. Strassburg | C. Strassburg | Y. D. de Boer | N. V. van Gerven | Chris Jj Mulder | Gerd Bouma
[1] D. V. van Thiel,et al. DISEASE RECURRENCE AND REJECTION FOLLOWING LIVER TRANSPLANTATION FOR AUTOIMMUNE CHRONIC ACTIVE LIVER DISEASE , 1992, Transplantation.
[2] J. Trotter,et al. Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[3] K. Lindor,et al. Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis. , 2000, Gastroenterology.
[4] J. Neuberger,et al. RECURRENCE OF AUTOIMMUNE CHRONIC ACTIVE HEPATITIS FOLLOWING ORTHOTOPIC LIVER GRAFTING , 1984, Transplantation.
[5] J. Newton,et al. Autoimmune hepatitis in older patients. , 1997, Age and ageing.
[6] F. Alvarez,et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitis , 1987, Hepatology.
[7] M. Heneghan,et al. Current and novel immunosuppressive therapy for autoimmune hepatitis , 2002, Hepatology.
[8] S. Pocock,et al. Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. , 1980, Gut.
[9] M. Khamashta,et al. Autoimmune diseases induced by TNF-targeted therapies. , 2008, Best practice & research. Clinical rheumatology.
[10] D. R. Parker,et al. Autoimmune hepatitis in the elderly , 1998, Gut.
[11] A. Lohse,et al. De novo autoimmune hepatitis after liver transplantation , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[12] M. Manns,et al. Long‐term outcome of liver transplantation for autoimmune hepatitis , 2004, Clinical transplantation.
[13] P. Galle,et al. Mycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis? , 2008, The American Journal of Gastroenterology.
[14] David C. Jones,et al. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis , 1999, Hepatology.
[15] K. Nagata,et al. Improvement of rheumatoid arthritis and autoimmune hepatitis in a patient treated with the tumor necrosis factor inhibitor, etanercept. , 2011, Internal medicine.
[16] E. Elias,et al. Recurrence of autoimmune hepatitis after liver transplantation. , 1999, Transplantation.
[17] G. Gerken,et al. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases. , 1997, Zeitschrift fur Gastroenterologie.
[18] N. Rose,et al. Hypothesis: the aging paradox and autoimmune disease. , 1991, Autoimmunity.
[19] M. Manns,et al. Recurrent autoimmune hepatitis after liver transplantation—when non‐self becomes self , 2000, Hepatology.
[20] M. Prelog. Aging of the immune system: a risk factor for autoimmunity? , 2006, Autoimmunity reviews.
[21] V. Balan,et al. Recurrence of autoimmune liver disease after liver transplantation: A systematic review , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[22] A. Czaja. Challenges in the diagnosis and management of autoimmune hepatitis. , 2013, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[23] B. Portmann,et al. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. , 2006, Journal of hepatology.
[24] M. Manns,et al. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. , 2010, Gastroenterology.
[25] M. L. de la Mata,et al. Outcome of autoimmune hepatitis after liver transplantation. , 1998, Transplantation.
[26] R. Wiesner,et al. Prognostic features and role of liver transplantation in severe corticosteroid‐treated autoimmune chronic active hepatitis , 1992, Hepatology.
[27] R. Brattsand,et al. Synthesis and anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid with high local activity. , 1980, Arzneimittel-Forschung.
[28] A. Czaja,et al. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly , 2006, Hepatology.
[29] Å. Danielsson,et al. Oral budesonide for treatment of autoimmune chronic active hepatitis , 1994, Alimentary pharmacology & therapeutics.
[30] F. Alvarez,et al. Short-term cyclosporine induces a remission of autoimmune hepatitis in children. , 1999, Journal of hepatology.
[31] A. Czaja. Diagnosis and management of autoimmune hepatitis , 2015, BMJ.
[32] J. Neuberger,et al. Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far? , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[33] M. Manns,et al. dvances in the Diagnosis , Pathogenesis , and Management of utoimmune Hepatitis , 2022 .
[34] W. Summerskill,et al. Classification and treatment of chronic active liver disease. , 1968, Gastroenterology.
[35] M. Manns,et al. Budesonide in previously untreated autoimmune hepatitis , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[36] D. Vergani,et al. Autoimmune hepatitis in childhood: A 20‐year experience , 1997, Hepatology.
[37] J. Neuberger,et al. The impact of disease recurrence on graft survival following liver transplantation: a single centre experience , 2008, Transplant international : official journal of the European Society for Organ Transplantation.
[38] K. Batts,et al. The nature and prognostic implications of autoimmune hepatitis with an acute presentation. , 1994, Journal of hepatology.
[39] P. Mcmaster,et al. Liver transplantation for autoimmune hepatitis: a 12-year experience. , 1997, Transplantation proceedings.
[40] A. Czaja,et al. Significance of HLA DR4 in type 1 autoimmune hepatitis. , 1993, Gastroenterology.
[41] M. Manns,et al. Autoimmune hepatitis in the elderly: what is the difference? , 2006, Journal of hepatology.
[42] J. Girardet,et al. Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis. , 1999, The Journal of pediatrics.
[43] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[44] F. Villamil,et al. Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis , 1999, American Journal of Gastroenterology.
[45] M. Manns,et al. Autoimmune hepatitis: clinical challenges. , 2001, Gastroenterology.
[46] B. Aqel,et al. Efficacy of Tacrolimus in the Treatment of Steroid Refractory Autoimmune Hepatitis , 2004, Journal of clinical gastroenterology.
[47] L. Elveback,et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. , 1972, Gastroenterology.
[48] P. D. James,et al. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. , 2000, Journal of hepatology.
[49] R. Williams,et al. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. , 1995, The New England journal of medicine.
[50] B. Portmann,et al. Recurrence of autoimmune hepatitis following liver transplantation. , 1995, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[51] D. V. van Thiel,et al. Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. , 1995, The American journal of gastroenterology.
[52] J. Vicario,et al. Response to steroids in de novo autoimmune hepatitis after liver transplantation , 2002, Hepatology.
[53] M. Manns,et al. Liver transplantation in autoimmune liver disease--selection of patients. , 1999, Hepato-gastroenterology.
[54] O. Farges,et al. Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. , 1999, Journal of hepatology.